Barr Pharmaceuticals was a global specialty and generic drug manufacturer with operations in 30 countries. Approximately 75% of the company's revenues were from the sale of generic drugs, including 18% of sales which were from the sale of oral contraceptive pills. It was acquired by Teva Pharmaceutical Industries in 2008 for an estimated 7.46 billion dollars.